Related Experiment Video
Updated: May 2, 2026

26:48
Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis
Published on: July 4, 2007
17.9K
ALERD: acute leukoencephalopathy with restricted diffusion-a newly emerging diagnosis
Abida Akbar1, Sanam Bano Rajper1, Sadam Hussain1
1Pediatrics and Child Health, The Aga Khan University Hospital, Karachi, Pakistan.
BMJ Case Reports
|April 5, 2025
Summary
Acute leukoencephalopathy with restricted diffusion (ALERD) is a severe syndrome often following infection. Prompt immunotherapy is crucial for improving outcomes in pediatric patients with ALERD.
Area of Science:
- Neurology
- Pediatrics
- Infectious Diseases
Background:
- Acute leukoencephalopathy with restricted diffusion (ALERD) is a severe clinical-radiological syndrome.
- It is characterized by encephalopathy, seizures, and restricted diffusion in the subcortical white matter.
- ALERD is associated with a higher incidence of neurological sequelae in children.
Purpose of the Study:
- To report three cases of ALERD following infection.
- To highlight the varying outcomes and the importance of early diagnosis and treatment.
Main Methods:
- Case series reporting three pediatric patients with ALERD.
- Clinical presentation, radiological findings (MRI), and outcomes were analyzed.
- Treatment with immunotherapy was administered in one case.
Main Results:
- All three cases followed a prodrome of fever and gastroenteritis, progressing to seizures and encephalopathy.
- Outcomes varied: one patient improved with immunotherapy and had mild sequelae, another had significant sequelae, and the third succumbed to death.
- One case presented with a central-sparing pattern on MRI but had rapid progression.
Conclusions:
- ALERD is a significant cause of acute encephalopathy in children.
- A high index of suspicion is required for prompt diagnosis.
- Early initiation of immunotherapy may lead to better neurological outcomes.
Related Concept Videos
Alzheimer's Disease: Overview
1.7K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
Encephalitis l: Introduction
15
Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
15
Cerebral Edema ll: Pathophysiology
19
Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this...
19
Alzheimer Disease l: Introduction
21
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
21
Dementia l: Introduction
35
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
35

